KRAS and cancer: The performance scores for these models were subsequently compared to the CIBRA impact score for five known cancer genes in metastatic CRC: TP53, APC, KRAS, BRAF, and PIK3CA, as well as a gene often mutated due to its size, TTN, with no reported impact.